PPAR agonists (High Point)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePPAR agonists (High Point)
Drug Alias NamePPAR agonists (Novo Nordisk)PPAR alpha/gamma triple agonists (Novo Nordisk)PPAR alpha/gamma dual agonists (Novo Nordisk)PPAR agonists (TransTech Pharma)NNC-61-5920
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists +[4] 
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVtv Therapeutics LlcNovo Nordisk A/SHigh Point Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A